Haoxi Health Technology Limited

HAO Communication Services Advertising Agencies

Haoxi Health Technology Limited’s revenue for fiscal 2026 (year ended June 2026) was $54.8 million, up 67.1% from fiscal 2025. Insiders bought in the last twelve months.

2.10 0.09 −4.11%
Market cap
$1.3M
P/E
—
Fwd P/E
—
Dividend yield
—
F-score
3/9
Altman Z
1.55
Beneish M
−3.04
Dividend safety
n/a

Insider Decisions trades per month

Total buys 0.72
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — 1 — — — — —
Sell — — — — — — — — — — — —
Insider Ownership —

Capital & Financial Ratios $m

Market Cap 1.34
Revenue —
Net Income (1.71)
Free Cash Flow (8.62)
Net Debt (5.22)
Current Ratio 3.45 (at or above 1.5: strong)
Debt/Equity 0.10 (at or below 0.5: strong)
P/E ratio —
Fwd P/E —
P/S ratio —
P/B ratio 0.00
Past 5Y EPS Growth —
This Y EPS Growth 296.50% (at or above 15%: strong)
Next Y EPS Growth —
Next Y revenue growth —
Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2020 0.01
0.01
2019 0.69
0.69
2018 1.20
1.20
2017 1.05
1.05
2016 0.76
0.76
special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 2026
Cash 1 7 9 11
Receivables 0 0 0 0
Inventory — — — —
Other 2 5 6 6
4 15 20 17
2023 2024 2025 2026
Payables 0 1 0 0
ST’ Debt 1 1 2 2
Other 1 1 1 1
3 4 4 4

Compound Annual Growth %

10y 5y 3y
Sales — 27.68% 24.77%
Cash Flow — — 0.00%
Earnings — 0.00% 0.00%
Book Value — 0.00% 125.07%

Revenue $m

Mar Jun Sep Dec Year
’26 — — — — —
’26 — — — — 55
’25 — — — — 33
’24 — — — — 49
’23 — — — — 28
’22 — — — — 16
’21 — — — — 16
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 — — — — —
’26 — — — — (3)
’25 — — — — (3)
’24 — — — — (1)
’23 — — — — (1)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 — — — — —
’26 — — — (2) (3)
’25 — (3) — (2) (5)
’24 — (1) — 0 (1)
’23 — (1) — — (1)
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 — — — — —
’26 — — — — (386.40)
’25 — — — — 3.38k
’24 — — — — 2.71k
’23 — — — — 2.25k
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to June

Group Line 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Trend 2027e 2028e 2029e
Price, $
Price, $ Low — — — — — — — 235.52 248.32 2.09

Analyst estimates 2027–2029

Powerpack
High — — — — — — — 27,136.00 10,240.00 4,352.00
People
People Employees — — — — — — 32 30 26 28
Revenue/emp, $m — — — — 0.00 0.00 0.88 1.62 1.26 1.96
Income, $m
Income, $m Revenue — — — — 16 16 28 49 33 55
Gross margin, % — — — — 4.02 4.02 7.30 5.67 2.83 1.15
EBT — — — — 0 (1) 1 2 4 (9)
EBT margin, % — — — — 1.61 0.00 4.22 3.58 12.64 (17.33)
Net income — — — — 0 0 1 1 4 (10)
Depreciation — — — — — 0 0 0 0 0
Per share, $
Per share, $ Revenue — — — — 0.00 40,392.25 70,573.00 97,039.60 36,449.22 2,219.79
Earnings — — — — — 627.15 2,251.24 2,569.10 4,256.42 (386.40)
Cash flow — — — — — (1,688.50) (2,180.25) (1,495.20) (3,731.22) (103.99)
Capex — — — — — (21.75) (113.75) (110.80) (2,311.11) 0.00
Free cash flow — — — — — (1,710.25) (2,294.00) (1,606.00) (6,042.33) (103.99)
Book value — — — — 0.00 (3,664.25) 3,916.25 22,544.00 19,307.11 723.06
Shares, m — — — — — 0 0 0 0 0
Valuation, ×
Valuation, × P/E — — — — — — — — — —
P/S — — — — — — — — — —
P/B — — — — 0.00 0.00 0.00 0.00 0.00 0.00
EV/Sales — — — — 0.00 0.00 0.00 0.00 0.00 0.00
EV/FCF — — — — 0.00 0.00 0.00 2.60 1.09 0.60
Cash, $m
Cash, $m Operating cash flow — — — — — (1) (1) (1) (3) (3)
Capex — — — — — 0 0 0 (2) —
Free cash flow — — — — — (1) (1) (1) (5) (3)
Balance, $m
Balance, $m Working capital — — — — (2) 0 1 12 16 13
Total debt — — — — — 0 1 1 2 2
Net debt — — — — 0 0 0 (6) (7) (9)
Shareholders’ equity — — — — (1) (1) 2 11 17 18
Returns, %
Returns, % ROA — — — — 45.05 352.21 43.37 12.94 20.90 (44.18)
ROIC — — — — 0.00 (202.75) 66.50 18.66 (11.71) (70.74)
ROE — — — — (15.90) 0.00 1,924.21 20.12 27.06 (54.13)
Negative figures in brackets.

All 10 years →

Fiscal years to Jun 2026 · fundamentals updated 8 Oct 2026

Charts ten years each

Haoxi Health Technology Limited vs peers in Advertising Agencies (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
KRKR 36Kr Holdings Inc. Sponsored ADR $5.5M — (loss-making) — (loss-making) +3.16% (above 0%: growing) n/m −99.56% (below 0%: shrinking) 55.93% (11.53%) Compare
CNET ZW Data Action Technologies Inc. $5.1M — (loss-making) — +18.98% (above 0%: growing) n/m −116.44% (below 0%: shrinking) 7.21% (58.44%) Compare
YDKG Yueda Digital Holding $4.8M — (loss-making) — (loss-making) −93.87% (below 0%: shrinking) n/m +94.68% (above 0%: growing) (159.11%) 0.00% Compare
CHR Cheer Holding, Inc. $3.6M 0.0× — (loss-making) +42.89% (above 0%: growing) +7.12% (above 0%: growing) +1.34% (above 0%: growing) 72.56% 43.62% Compare
TC Token Cat Limited - Sponsored ADR $2.4M — (loss-making) — (loss-making) −48.54% (below 0%: shrinking) n/m −61.75% (below 0%: shrinking) 76.44% (51.72%) Compare
VSME VS MEDIA Holdings Limited $2.2M — — — — +51.31% (above 0%: growing) — — Compare
HAO Haoxi Health Technology Limited $1.3M — — — — −895.86% (below 0%: shrinking) — —
SOPAQ Society Pass Incorporated $980.0K — (loss-making) — (loss-making) −17.63% (below 0%: shrinking) n/m −920.18% (below 0%: shrinking) 64.28% (379.93%) Compare
DRCT Direct Digital Holdings, Inc. $730.0K — (loss-making) 11.5× −22.79% (below 0%: shrinking) n/m +67.42% (above 0%: growing) 34.00% (37.39%) Compare
Median of peers $3.0M — — −17.63% — −30.21% 55.93% (37.39%)

All 42 Advertising Agencies stocks →

Haoxi Health Technology Limited (HAO) key facts

  • Strength: Haoxi Health Technology Limited’s revenue for fiscal 2026 (year ended June 2026) was $54.8 million, up 67.1% from fiscal 2025.
  • Haoxi Health Technology Limited (HAO) is an Advertising Agencies company in the Communication Services sector, listed on Nasdaq.
  • As of October 16, 2026, HAO traded at $2.10, a market capitalization of $1.3 million.
  • Return on equity was −54.1% and debt-to-equity 0.10.
  • Its Piotroski F-score is 3 out of 9 and its Altman Z-score is 1.55 (distress zone) for fiscal 2026.

Source: company filings (standardised) and stockrow calculations · fundamentals updated Oct 8, 2026.

Haoxi Health Technology Limited (HAO) Latest News

No news at this impact. Lower the threshold for more.

stockrow.com/HAO · Data as of Oct 8, 2026 · For information only; not investment advice. · © 2026 stockrow.com